News

Inflammatory Arthritis awareness campaign: Have you got the 'S' factor

21 May 2010

Developed by the Rheumatology Futures Project Group (RFPG) and endorsed and supported by Arthritis Research UK, the Royal College of GPs and The Primary Care Rheumatology Society. View posters and further details

---

Health inequalities must be tackled by a National Clinical Director

30 March 2010

View BSR's position statement on a National Clinical Director for Musculoskeletal Conditions

---

Updated advice on swine flu vaccines for immunosuppressed patients from the DH

10 December 2009

View updated advice on swine flu relevant for rheumatology patients

---

National Audit Office conference: Improving Services for People with Rheumatoid Arthritis

9 December 2009

The NAO report provided a powerful lever for rheumatologists to change local services. The conference on 8 December focused on the report’s findings and recommendations. Professor Dame Carol Black was the keynote speaker.
Chair of BSR's Clinical Affairs Committee, Dr Chris Deighton, presented the current picture of rheumatoid arthritis care:



View the entire conference here

---

Press releases

NICE FAD on Tocilizumab for the treatment of RA
2 July 2010

NICE FAD on adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis (RA) after the failure of a TNF inhibitor

25 June 2010

Report from the Public Accounts Committee into Services for People with RA

23 February 2010

NICE decision on use of Certolizumab pegol for rheumatoid arthritis
21 January 2010

NAO Report: Services for People with Rheumatoid Arthritis
15 July 2009

Swine Flu and Patients on Anti-TNF
14 July 2009

NICE Appraisal for adalimumab, etanercept and infliximab for RA after failure of a previous anti-TNF
24 Nov 2008

ARMA's statement on NICE's decision on switching Anti-TNF for RA
21 July 2008

Health Select Committee report on MMC
9 May 2008

Lancet Report on NICE
8 May 2008

Alcohol and arthritis
May 2008

Sequential use of adalimumab, etanercept and infliximab for rheumatoid arthritis
April 2008

NICE Appeal Committee decision on Abatacept for rheumatoid arthritis
April 2008

Gout
February 2008

Lumiracoxib
19 November 2007

NICE decision on Rituximab for rheumatoid arthritis
22 August 2007

NICE document on Abatacept for rheumatoid arthritis
2 August 2007

NICE appeal for alternative anti-TNF
12 June 2007

Launch of Musculoskeletal Services Framework (MSF)
1 November 2006

EMEA Announcement on NSAIDS
25 October 2006

Choose and Book keywords & clinic types
16 October 2006

Musculoskeletal Services Framework
8 September 2006

NPSA reissues Methotrexate guidance
July 2006